Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313328131> ?p ?o ?g. }
- W4313328131 endingPage "38" @default.
- W4313328131 startingPage "38" @default.
- W4313328131 abstract "Breast cancer (BC) is the most commonly diagnosed cancer globally, with high mortality rates. Targeted drug therapies have revolutionized cancer treatment. For example, treatment with human epidermal receptor 2 (HER2) antagonists has markedly improved the prognosis of patients with HER2-positive BC (HER2 + BC). However, HER2+ metastatic BC (MBC) remains prevalent owing to its resistance to conventional anti-HER2 drugs. Therefore, novel agents are needed to overcome the limitations of existing cancer treatments and to enhance the progression-free and overall survival rates. Progress has been made by optimizing the fragment crystallizable (Fc) domain of trastuzumab, an IgG1 monoclonal, chimeric anti-HER2 antibody, to develop margetuximab. The modified Fc domain of margetuximab enhances its binding affinity to CD16A and decreases its binding affinity to CD32B, thereby promoting its antitumor activity. This review summarizes studies on the efficacy of margetuximab, discusses its utility as an anti-HER2 monoclonal antibody drug for the treatment of HER2 + BC, and presents the latest advances in the treatment of BC. This review provides insights into the clinical implication of margetuximab in HER2 + MBC treatment." @default.
- W4313328131 created "2023-01-06" @default.
- W4313328131 creator A5037161140 @default.
- W4313328131 date "2022-12-21" @default.
- W4313328131 modified "2023-10-14" @default.
- W4313328131 title "A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer" @default.
- W4313328131 cites W1491128979 @default.
- W4313328131 cites W1568927316 @default.
- W4313328131 cites W1621402431 @default.
- W4313328131 cites W1838685504 @default.
- W4313328131 cites W1966240013 @default.
- W4313328131 cites W1976677664 @default.
- W4313328131 cites W2000714108 @default.
- W4313328131 cites W2006710185 @default.
- W4313328131 cites W2008790865 @default.
- W4313328131 cites W2025151336 @default.
- W4313328131 cites W2064416108 @default.
- W4313328131 cites W2070727232 @default.
- W4313328131 cites W2078454159 @default.
- W4313328131 cites W2087947321 @default.
- W4313328131 cites W2117115931 @default.
- W4313328131 cites W2133105825 @default.
- W4313328131 cites W2142752401 @default.
- W4313328131 cites W2154246971 @default.
- W4313328131 cites W2172114959 @default.
- W4313328131 cites W2172118845 @default.
- W4313328131 cites W2187882993 @default.
- W4313328131 cites W2234071502 @default.
- W4313328131 cites W2280869417 @default.
- W4313328131 cites W2410844658 @default.
- W4313328131 cites W2420100166 @default.
- W4313328131 cites W2580453358 @default.
- W4313328131 cites W2582248920 @default.
- W4313328131 cites W2585754738 @default.
- W4313328131 cites W2615601352 @default.
- W4313328131 cites W2723461340 @default.
- W4313328131 cites W2734700058 @default.
- W4313328131 cites W2745112655 @default.
- W4313328131 cites W2752201538 @default.
- W4313328131 cites W2755901993 @default.
- W4313328131 cites W2763907629 @default.
- W4313328131 cites W2768980003 @default.
- W4313328131 cites W2773992597 @default.
- W4313328131 cites W2795688435 @default.
- W4313328131 cites W2807500538 @default.
- W4313328131 cites W2895051293 @default.
- W4313328131 cites W2897992036 @default.
- W4313328131 cites W2906314010 @default.
- W4313328131 cites W2907730341 @default.
- W4313328131 cites W2920995016 @default.
- W4313328131 cites W2942790586 @default.
- W4313328131 cites W2966214016 @default.
- W4313328131 cites W2971540609 @default.
- W4313328131 cites W2972399366 @default.
- W4313328131 cites W2986511818 @default.
- W4313328131 cites W2995764973 @default.
- W4313328131 cites W2998950563 @default.
- W4313328131 cites W3008628679 @default.
- W4313328131 cites W3011274212 @default.
- W4313328131 cites W3022873345 @default.
- W4313328131 cites W3024455139 @default.
- W4313328131 cites W3027335902 @default.
- W4313328131 cites W3032486070 @default.
- W4313328131 cites W3035185524 @default.
- W4313328131 cites W3042132061 @default.
- W4313328131 cites W3061431577 @default.
- W4313328131 cites W3094158995 @default.
- W4313328131 cites W3106728899 @default.
- W4313328131 cites W3109189796 @default.
- W4313328131 cites W3112435142 @default.
- W4313328131 cites W3112886473 @default.
- W4313328131 cites W3123743675 @default.
- W4313328131 cites W3128646645 @default.
- W4313328131 cites W3158359283 @default.
- W4313328131 cites W3182027726 @default.
- W4313328131 cites W4247435334 @default.
- W4313328131 cites W4308254239 @default.
- W4313328131 doi "https://doi.org/10.3390/cancers15010038" @default.
- W4313328131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36612034" @default.
- W4313328131 hasPublicationYear "2022" @default.
- W4313328131 type Work @default.
- W4313328131 citedByCount "1" @default.
- W4313328131 crossrefType "journal-article" @default.
- W4313328131 hasAuthorship W4313328131A5037161140 @default.
- W4313328131 hasBestOaLocation W43133281311 @default.
- W4313328131 hasConcept C121608353 @default.
- W4313328131 hasConcept C126322002 @default.
- W4313328131 hasConcept C143998085 @default.
- W4313328131 hasConcept C159654299 @default.
- W4313328131 hasConcept C203014093 @default.
- W4313328131 hasConcept C2775930923 @default.
- W4313328131 hasConcept C2777329042 @default.
- W4313328131 hasConcept C2779786085 @default.
- W4313328131 hasConcept C502942594 @default.
- W4313328131 hasConcept C530470458 @default.
- W4313328131 hasConcept C542903549 @default.
- W4313328131 hasConcept C71924100 @default.
- W4313328131 hasConcept C98274493 @default.